🔎 Trials Near Me

Gara Jalqabaatti › Obesity › Virginia › Arlington

Qorannoo klinikaalii Obesity Arlington, VA keessatti

Qorannoo 18 Obesity f Arlington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Namoota walitti qabaa jiraSadarkaa 3
  • Washington Center for Weight Management and Research, Inc, Arlington
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Namoota walitti qabaa jiraSadarkaa 3
  • Manassas Clinical Research Center Inc, Burke · Miili 11 fagaatti
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684144

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Virginia Heart, Falls Church · Miili 4 fagaatti
  • Inova Cardiology - Fairfax, Fairfax · Miili 11 fagaatti
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Namoota walitti qabaa jiraSadarkaa 2
  • Washington Center For Weight Management And Research /ID# 282047, Arlington
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Namoota walitti qabaa jiraSadarkaa 2
  • Carient Heart and Vascular LLC-Reston, Reston · Miili 14 fagaatti
  • Carient Heart & Vascular - Manassas, Manassas · Miili 22 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07783802

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Namoota walitti qabaa jiraSadarkaa 3
  • Washington Cntr Weight Mgmt, Arlington
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07720271

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Manassas · Miili 22 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07776509

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Namoota walitti qabaa jiraSadarkaa 3
  • Washington Cntr Weight Mgmt, Arlington
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07339423

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Manassas · Miili 22 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Conquest Research, LLC, Arlington
  • Virginia Heart, Falls Church · Miili 4 fagaatti
  • Carient Heart and Vascular, Manassas · Miili 22 fagaatti
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Manassas Clinical Research Center, Manassas · Miili 22 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
  • ACCOMPLISH-2 Research Site, Burke · Miili 11 fagaatti
  • ACCOMPLISH-2 Research Site, Manassas · Miili 22 fagaatti
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailera Clinical Site, Manassas · Miili 22 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailera Clinical Site, Manassas · Miili 22 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07284979

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Arlington
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Conquest Research, Vienna · Miili 9 fagaatti
  • Carient Heart and Vascular, Manassas · Miili 22 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07567001

Brief Inhibitory Training for Eating - Intervention

Namoota walitti qabaa jira
  • George Mason University, Fairfax · Miili 11 fagaatti
Umuriin 14 hanga 17 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT07592728

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
  • Vanda Investigational Site, Burke · Miili 11 fagaatti
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 20-Elb-2026 · NCT07446439

Qorannoo Obesity magaalota biroo keessatti

Qorannoo biroo Arlington keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.